Page last updated: 2024-12-10

iodotamoxifen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

iodotamoxifen: RN given refers to unlabeled cpd(Z)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3035792
MeSH IDM0107955

Synonyms (7)

Synonym
iodotamoxifen
[131I]TAM
[131i]tamoxifen
131i-labeled [z]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-n,n-dimethylethanamine
2-[4-[(z)-1,2-diphenylbut-1-enyl]-2-iodophenoxy]-n,n-dimethylethanamine
76070-10-5
ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)-2-iodophenoxy)-n,n-dimethyl-, (z)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]